Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases-Reference-Cited by-同舟云学术

Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases

Published:2007-06 Issue:2 Volume:5 Page:194-202
ISSN:1540-4196
Container-title:Metabolic Syndrome and Related Disorders
language:en
Short-container-title:Metabolic Syndrome and Related Disorders

Author:

Michelini E.¹,Lonardo A.¹,Ballestri S.¹,Costantini M.²,Caporali C.³,Bonati M.E.¹,Bertolotti M.¹,Iori R.¹,Loria P.¹

Affiliation:

1. Dipartimento Integrato di Medicina, Endocrinologia, Metabolismo, e Geriatria—Nuovo Ospedale Civile S. Agostino-Estense di Baggiovara, Modena, Italy.

2. Dipartimento di Anatomia e Istologia—Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.

3. Dipartimento Integrato di Servizi diagnostici e per immagine—Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/met.2006.0018

Reference27 articles.

1. Cholangiocarcinoma

2. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

3. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

4. The Epidemiology of Cholangiocarcinoma

5. Cholangiocarcinoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extra-hepatic cancers in metabolic fatty liver syndromes;Exploration of Digestive Diseases;2023-02-24

2. Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations;Journal of Hepato-Biliary-Pancreatic Sciences;2021-06-17

3. Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes;Diabetes;2018-05-04

4. AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions;Digestive and Liver Disease;2017-05

5. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV;World Journal of Gastroenterology;2016